Chronic Kidney Disease (CKD) is a persistent abnormality in kidney function or
structure, with or without a decline in glomerular filtration rate (GFR) below 60
mL/min/1.73 m², lasting for more than three months. CKD diagnosis relies on markers
of kidney damage and/or a reduction in GFR. Patients with advanced CKD,
characterized by a GFR below 15 mL/min/1.73 m², typically require dialysis. In 2018,
60,852 individuals in Indonesia were reported to have CKD requiring lifelong dialysis.
This study aims to assess the characteristics of CKD patients undergoing hemodialysis.
This research employs descriptive design. The sample consists of all CKD patients
undergoing hemodialysis, as recorded in the medical records of RSPAL dr. Ramelan
Surabaya between January and June 2022. The findings reveal that more than half of the
patients (52.7%) had been on hemodialysis for more than 12 months. Many of the
patients (66.2%) were between 40 and 60 years old, with males accounting for 54.1% of
the sample. Hypertension and diabetes mellitus were identified as the most common
comorbid conditions (31.1%), while pain medication consumption was the least reported
cause (2.7%). All patients had hemoglobin levels below the normal range (<13 g/dL for
males and <12 g/dL for females) and relied on BPJS (Indonesia’s national health
insurance) to cover the cost of hemodialysis. Furthermore, most patients exhibited
creatinine levels exceeding 1.5 mg/dL, blood urea nitrogen (BUN) levels above 24
mg/dL, serum iron (SI) levels between 45 and 158 µg/dL, and total iron-binding
capacity (TIBC) levels below 250 µg/dL.